Literature DB >> 20074038

Cyclin A and Nek2A: APC/C-Cdc20 substrates invisible to the mitotic spindle checkpoint.

Wouter van Zon1, Rob M F Wolthuis.   

Abstract

Active cyclin B1-Cdk1 (cyclin-dependent kinase 1) keeps cells in mitosis, allowing time for spindle microtubules to capture the chromosomes and for incorrect chromosome-spindle attachments to be repaired. Meanwhile, securin, an inhibitor of separase, secures cohesion between sister chromatids, preventing anaphase onset. The spindle checkpoint is a signalling pathway emerging from improperly attached chromosomes that inhibits Cdc20, the mitotic activator of the APC/C (anaphase-promoting complex/cyclosome) ubiquitin ligase. Blocking Cdc20 stabilizes cyclin B1 and securin to delay mitotic exit and anaphase until all chromosomes reach bipolar spindle attachments. Cells entering mitosis in the absence of a functional spindle checkpoint degrade cyclin B1 and securin right after nuclear-envelope breakdown, in prometaphase. Interestingly, two APC/C substrates, cyclin A and Nek2A, are normally degraded at nuclear-envelope breakdown, even when the spindle checkpoint is active. This indicates that the APC/C is activated early in mitosis, whereas cyclin B1 and securin are protected as long as the spindle checkpoint inhibits Cdc20. Remarkably, destruction of cyclin A and Nek2A also depends on Cdc20. The paradox of Cdc20 being both active and inhibited in prometaphase could be explained if cyclin A and Nek2A are either exceptionally efficient Cdc20 substrates, or if they are equipped with 'stealth' mechanisms to effectively escape detection by the spindle checkpoint. In the present paper, we discuss recently emerging models for spindle-checkpoint-independent APC/C-Cdc20 activity, which might even have implications for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074038     DOI: 10.1042/BST0380072

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  16 in total

1.  Distinct roles of cohesin acetyltransferases Esco1 and Esco2 in porcine oocyte meiosis I.

Authors:  Yajuan Lu; Ying Chen; Zhaokang Cui; Bo Xiong
Journal:  Cell Cycle       Date:  2019-08-06       Impact factor: 4.534

2.  Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis.

Authors:  Yueyang Yu; Karl Munger
Journal:  Virology       Date:  2013-09-05       Impact factor: 3.616

Review 3.  Spatiotemporal regulation of the anaphase-promoting complex in mitosis.

Authors:  Sushama Sivakumar; Gary J Gorbsky
Journal:  Nat Rev Mol Cell Biol       Date:  2015-02       Impact factor: 94.444

4.  Meiotic progression in Arabidopsis is governed by complex regulatory interactions between SMG7, TDM1, and the meiosis I-specific cyclin TAM.

Authors:  Petra Bulankova; Nina Riehs-Kearnan; Moritz K Nowack; Arp Schnittger; Karel Riha
Journal:  Plant Cell       Date:  2010-11-30       Impact factor: 11.277

5.  Regulation of APC/CCdc20 activity by RASSF1A-APC/CCdc20 circuitry.

Authors:  C Chow; N Wong; M Pagano; S W-M Lun; K-I Nakayama; K Nakayama; K-W Lo
Journal:  Oncogene       Date:  2011-08-29       Impact factor: 9.867

6.  Cohesion fatigue explains why pharmacological inhibition of the APC/C induces a spindle checkpoint-dependent mitotic arrest.

Authors:  Pablo Lara-Gonzalez; Stephen S Taylor
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

7.  The APC/C recruits cyclin B1-Cdk1-Cks in prometaphase before D box recognition to control mitotic exit.

Authors:  Wouter van Zon; Janneke Ogink; Bas ter Riet; René H Medema; Hein te Riele; Rob M F Wolthuis
Journal:  J Cell Biol       Date:  2010-08-23       Impact factor: 10.539

8.  Cks1: Structure, Emerging Roles and Implications in Multiple Cancers.

Authors:  Vinayak Khattar; Jaideep V Thottassery
Journal:  J Cancer Ther       Date:  2013-10-01

9.  Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.

Authors:  Eri Arai; Masahiro Gotoh; Ying Tian; Hiromi Sakamoto; Masaya Ono; Akio Matsuda; Yoriko Takahashi; Sayaka Miyata; Hirohiko Totsuka; Suenori Chiku; Motokiyo Komiyama; Hiroyuki Fujimoto; Kenji Matsumoto; Tesshi Yamada; Teruhiko Yoshida; Yae Kanai
Journal:  Int J Cancer       Date:  2015-06-30       Impact factor: 7.396

Review 10.  The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer.

Authors:  Florian Bassermann; Ruth Eichner; Michele Pagano
Journal:  Biochim Biophys Acta       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.